A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to trea... by Mirjam Gross-Erne, Lukas Zimmerli, Stefano Bassetti, Qiyu Li, Anita Feller, Walter Mingrone

“…The 5-year overall survival for breast cancer (unadjusted for stage) was significantly higher in the NACR collective (84.5%) than in the Olten collective (79.7%) but not for the individual breast cancer stages. The Olten collective included approximately 2.5 times as many patients with stage 4 breast cancer (17.5%) as the NACR collective (6.9%). …”
Get full text

Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy by Cristina Zarotti, Bärbel Papassotiropoulos, Constanze Elfgen, Konstantin Dedes, Denise Vorburger, Bernhard Pestalozzi, Andreas Trojan, Zsuzsanna Varga

“…This retrospective study addresses the question how biomarker profiles and treatment modalities in the neoadjuvant chemotherapy setting have changed during the past 15 years and what prognostic impact these changes implicate. 342 female breast cancer stage I-IV patients receiving neoadjuvant chemotherapy between 2003 and 2017 were analyzed. …”
Get full text

Quality of Colon Cancer Care in Patients Undergoing Emergency Surgery by Keegan Guidolin, Rebecca Withers, Farhana Shariff, Shady Ashamalla, Ashlie Nadler

“…Patients who underwent a colon cancer resection from January 2017 to February 2019 were matched by age, sex, and cancer stage. Data were collected through the National Surgical Quality Improvement Program and chart review. …”
Get full text

Influence of Comorbidity Burden, Socioeconomic Status, and Race and Ethnicity on Survival Disparities in Patients With Cancer by Robert M. Cooper, Chun Chao, Amrita Mukherjee, Zimin Zhuang, Reina Haque

“…After adjusting for age, sex, race/ethnicity, cancer stage, smoking status, insurance payor, medical center, year of cancer diagnosis, and cancer treatments, we observed a trend demonstrating higher mortality risk by decreasing socioeconomic status (SES) (P-trend<.05). …”
Get full text

Influential Factors and Personalized Prediction Model of Acute Pain Trajectories after Surgery for Renal Cell Carcinoma by Hsin-Jung Tsai, Wen-Kuei Chang, Fang-Yu Yen, Shih-Pin Lin, Tzu-Ping Lin, Kuang-Yi Chang

“…Latent curve analysis identified that female patients and those with advanced cancer (stage III and IV) tended to have increased baseline pain scores (<i>p</i> = 0.028 and 0.012, respectively). …”
Get full text

Real‐world effectiveness of lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice by Amit G. Singal, Saurabh P. Nagar, Abby Hitchens, Keith L. Davis, Shrividya Iyer

“…Most patients had Barcelona Clinic Liver Cancer stage B (23.8%) or C (38.4%) uHCC. Median duration of lenvatinib treatment was 6.9 months, with 42.7% of patients still on treatment at the end of follow‐up. …”
Get full text

Survival analysis of localized prostate cancer with deep learning by Xin Dai, Ji Hwan Park, Shinjae Yoo, Nicholas D’Imperio, Benjamin H. McMahon, Christopher T. Rentsch, Janet P. Tate, Amy C. Justice

“…We find PSA and prostate cancer stage information are the most important indicators in risk prediction. …”
Get full text

Curative resection after percutaneous drainage followed by preoperative panitumumab monotherapy for locally advanced sigmoid colon cancer with intra-abdominal abscess: a case repor... by Yusuke Asada, Fumitaka Nakayama, Takashi Takenoya, Ippei Oto, Tetsuya Nakamura, Koji Osumi, Noriaki Kameyama

“…The diagnosis was locally advanced sigmoid colon cancer stage IIIC (T4bN2aM0) with a large intra-abdominal abscess. …”
Get full text

Factors affecting delay in the presentation of breast cancer symptoms among women in Gaza, occupied Palestinian territory: a cross-sectional survey by Elizabeth A Davies, Samira S Abo Al-Shiekh, Yasser S Alajerami, Khaled M Abushab, Ahmed A Najim, Shaymaa AlWaheidi

“…Their mean age was 51 years (range: 23–72), 33.6% (31/122) had a family history of breast cancer and 74.5% (41/55) of those whose cancer stage was known had been diagnosed at stage III or IV. …”
Get full text

Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer by Voloudakis-Baltatzis Irene, Katsantoni Eleni Z, Vassilaros Stamatis D, Vlachodimitropoulos Dimitrios, Goutas Nikos, Arvanitis Leonidas D, Drosos Yiannis, Amawi Kawther, Kouloukoussa Mirsini, Havaki Sophia, Aleporou-Marinou Vassiliki, Kittas Christos, Marinos Evangelos

“…It has been well established that integrins play a major role in various cancer stages, such as tumor growth, progression, invasion and metastasis. …”
Get full text

Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary by Huijie Wu, Shaotao Jiang, Peiwen Zhong, Weiru Li, Siyou Zhang

“…Univariate and multivariate Cox models suggested that age (HR=1.28, 95% CI[1.15,1.44]), grade (HR=1.26, 95% CI[1.12,1.41]), SEER stage (HR=1.63, 95% CI[1.25,2.13]) and AJCC (American Joint Committee on Cancer) stage (HR=1.59, 95% CI[1.36,1.86]) were independent prognostic factors for MCOA patients. …”
Get full text

Racial disparities in opioid prescription and pain management among breast cancer survivors by Sunny Jung Kim, Reuben P. Retnam, Arnethea L. Sutton, Megan C. Edmonds, Dipankar Bandyopadhyay, Vanessa B. Sheppard

“…Black patients were more likely to be prescribed opioids for 90 days or longer compared to White patients, when controlling for age, marital status, income, body mass index (BMI), cancer stage, and chemotherapy status (adjusted Odds Ratio = 2.72, p = 0.014). …”
Get full text

Study of Serum Lactate Dehydrogenase and Gamma-Glutamyl Transpeptidase in Breast Cancer Patients receiving Chemotherapy. by Anil Singh Basnyat, Abimanyu Jha, R Pathak, Bhupal Govinda Shrestha

“…A total number of 150 subjects were included in the study, comprising 90 histopathologically confirmed 24 to 76 years aged patients of different breast cancer stages, receiving at least 3 cycles of 5-Fluorouracil, Adriamycin and Cyclophosphamide (FAC) chemotherapy. …”
Get full text

Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining by Chaitra N, Sundar RNS, Kumar HKS, Nataraju G, Esaivani KB

“…Methods: This is a cross sectional study which included 30 cases of colorectal carcinomas. cytokeratin 20 stained slides of colorectal carcinoma were assesed for tumor budding using International Tumor Budding Consensus Conference (ITBCC) 2016 consensus criteria and compared with AJCC cancer stage. Results: Demographic analysis showed peak incidence of colorectal cancer in the age group of 55-64 years (33.3%) and male: female ratio of 1.14:1. …”
Get full text

Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry by Sofia Palmér, Carl Blomqvist, Marit Holmqvist, Henrik Lindman, Mats Lambe, Johan Ahlgren

“…Methods Validation by re-abstraction was performed on a random sample of 800 women with primary invasive breast cancer stage I-III diagnosed between 1993 and 2010, of which 400 had at least one registered recurrence and 400 had no registered recurrence. …”
Get full text

Treatment Strategy for Dialysis Patient with Urothelial Carcinoma by Yun-Ching Huang, Yu-Liang Liu, Miao-Fen Chen, Chih-Shou Chen, Chun-Te Wu

“…According to multivariate analysis with Cox regression, age > 70 years (HR 2.70, 95% CI 1.2–6.12; <i>p</i> = 0.017), CCI ≥ 5 (HR 2.16, 95% CI 1.01–4.63; <i>p</i> = 0.048), and bladder cancer stage ≥ 3 (HR 12.4, 95% CI 1.82–84.7; <i>p</i> = 0.010) were independent, unfavorable prognostic factors for the overall survival. …”
Get full text

Polyradiomodification in combined treatment for rectal cancer and the role of therapeutic pathomorphosis by Yu. A. Barsukov, O. A. Vlasov, S. S. Gordeev, A. G. Perevoschikov, V. F. Tsaryuk, V. A. Aliev

“…We assessed the frequency of relapses, metastases, and relapse-free survival depending on the grade of therapeutic pathomorphosis and cancer stage. Results. Median follow-up time was 48.5 months. …”
Get full text

Nomogram for prognosis of elderly patients with cervical cancer who receive combined radiotherapy by Wenjuan Chen, Xiaoyi Xia, Xingyun Xie, Yuting Wei, Rongrong Wu, Wenjie Cai, Jinsheng Hong

“…A review was conducted of 367 elderly women with cervical cancer (staged II–III) who had undergone radiotherapy in our hospital between January 2012 and December 2016. …”
Get full text

The effect of spread through air spaces on postoperative recurrence-free survival in patients with multiple primary lung cancers by Hongsheng Xie, Shihua Dou, Xiaoxiang Huang, Yuxin Wen, Lin Yang

“…Abstract Purpose The purpose of the study was to investigate the effect of spread through air spaces (STAS) on the postoperative prognosis of patients with multiple primary lung cancers staged from IA to IB based on tumor size. Methods Clinicopathological and follow-up data of 122 patients with multiple primary lung cancers diagnosed at stages IA-IB and surgically treated at the Department of Thoracic Surgery, Shenzhen people’s Hospital from January 2019 to December 2021 were retrospectively analyzed. …”
Get full text

Early integration of palliative care in cervical cancer: Experiences from a pilot study by Treshita Dey, Anindya Mukerjee, Bhavana Rai, Minni Arora, Divyesh Kumar, G Y Srinivasa, Sushmita Ghoshal

“…Material and Methods: Patients with locally advanced cervical cancer (stage IB2 to IIIB) having eastern cooperative oncology group (ECOG) performance score 0–2 were randomized into EIPC arm and standard of care arm of concurrent chemoradiation by a computer-generated table of random numbers. …”
Get full text